Literature DB >> 22114816

Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma.

Hung-Jui Tan1, Khaled S Hafez, Zaojun Ye, John T Wei, David C Miller.   

Abstract

PURPOSE: In addition to their acute implications, adverse events after oncological surgery may have late or long-term consequences for patient outcomes. We assessed the relationship between postoperative complications and long-term survival among patients treated surgically for kidney cancer.
MATERIALS AND METHODS: Using Surveillance, Epidemiology and End Results-Medicare data we identified patients with kidney cancer treated surgically from 1995 through 2005. After excluding from analysis those who died during the index hospitalization or within 30 days of surgery we compared overall survival for patients with or without a postoperative complication. We then fit multivariate Cox proportional hazard models to estimate the association between complications and long-term survival, adjusting for patient characteristics, cancer severity and surgical approach.
RESULTS: We identified 4,687 (37%) and 7,931 patients (63%) with and without a postoperative complication, respectively. During a median followup of 32 months (range 1 to 132) 3,425 patients (27.1%) died of any cause. Patients with at least 1 postoperative complication had lower unadjusted 5-year survival (59.9% vs 69.5%, p <0.001). On multivariate analyses the occurrence of a complication was also associated with significantly worse long-term survival (HR 1.24, 95% CI 1.16-1.33). This relationship was consistent with time, across surgical approaches and among patients with various specific complications, including acute renal failure, cardiac and neurological events, postoperative infection and sepsis.
CONCLUSIONS: The occurrence of a postoperative complication is associated with decreased long-term survival after surgery for kidney cancer. Clarification of the cascade of events underlying this relationship may lead to new strategies to improve outcomes among cancer survivors.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22114816     DOI: 10.1016/j.juro.2011.09.031

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.

Authors:  Furkan Dursun; Ahmed Elshabrawy; Hanzhang Wang; Ronald Rodriguez; Michael A Liss; Dharam Kaushik; Jonathan Gelfond; Ahmed M Mansour
Journal:  Int J Clin Oncol       Date:  2022-03-23       Impact factor: 3.402

2.  Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis.

Authors:  Veena Sangwan; Luai Al-Marzouki; Sanjima Pal; Vivian Stavrakos; Malak Alzahrani; Dorothy Antonatos; Yehonatan Nevo; Sophie Camilleri-Broët; Roni Rayes; France Bourdeau; Betty Giannias; Nicholas Bertos; Swneke Bailey; Simon Rousseau; Jonathan Cools-Lartigue; Jonathan D Spicer; Lorenzo Ferri
Journal:  Clin Exp Metastasis       Date:  2021-11-12       Impact factor: 5.150

Review 3.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

4.  Preoperative hypoalbuminemia and anemia as predictors of transfusion in radical nephrectomy for renal cell carcinoma: a retrospective study.

Authors:  Kyungmi Kim; Hyungseok Seo; Ji-Hyun Chin; Hyo-Jung Son; Jai-Hyun Hwang; Young-Kug Kim
Journal:  BMC Anesthesiol       Date:  2015-07-21       Impact factor: 2.217

5.  Prognostic Implications of Postoperative Infectious Complications in Non-Small Cell Lung Cancer.

Authors:  Hyo-Jun Jang; Jae Won Song; Sukki Cho; Kwhanmien Kim; Sanghoon Jheon
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-02-05

6.  Beta2-adrenoceptor stimulation suppresses TLR9-dependent IFNA1 secretion in human peripheral blood mononuclear cells.

Authors:  Tobias Hilbert; Josef Bongartz; Christina Weisheit; Pascal Knüfermann; Georg Baumgarten; Andreas Hoeft; Jens M Poth
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

7.  Percutaneous radiofrequency ablation of renal tumors: a single-center experience.

Authors:  Stephan Seklehner; Hermann Fellner; Paul F Engelhardt; Christoph Schabauer; Claus Riedl
Journal:  Korean J Urol       Date:  2013-09-10

8.  There is no place for targeted therapy neoadjuvant treatment in Polish Health System - An analysis of radical nephrectomies in patients with large kidney tumors.

Authors:  Jakub Kłącz; Marcin Matuszewski; Jerzy Michajłowski; Wojciech Zachalski; Marcin Markuszewski; Kazimierz Krajka
Journal:  Cent European J Urol       Date:  2013-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.